Healthcare provider profile · identity verified

Linsey Clarke, DO

Family Practice · BRIDGEWATER, VA · NPI 1215433842

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	754	239
Amlodipine Besylate	Amlodipine Besylate	509	161
Losartan Potassium	Losartan Potassium	439	135
Hydrochlorothiazide	Hydrochlorothiazide	292	97
Lisinopril	Lisinopril	281	86
Levothyroxine Sodium	Levothyroxine Sodium	277	85
Omeprazole	Omeprazole	230	77
Gabapentin	Gabapentin	204	69
Simvastatin	Simvastatin	194	53
Rosuvastatin Calcium	Rosuvastatin Calcium	192	57
Metformin Hcl	Metformin Hcl	189	63
Albuterol Sulfate Hfa	Albuterol Sulfate	187	72
Trazodone Hcl	Trazodone Hcl	182	60
Metoprolol Succinate	Metoprolol Succinate	165	44
Metoprolol Tartrate	Metoprolol Tartrate	142	45
Citalopram Hbr	Citalopram Hydrobromide	137	44
Furosemide	Furosemide	127	45
Allopurinol	Allopurinol	119	37
Sertraline Hcl	Sertraline Hcl	109	35
Tamsulosin Hcl	Tamsulosin Hcl	109	36
Eliquis	Apixaban	108	28
Pantoprazole Sodium	Pantoprazole Sodium	106	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	98	17
Famotidine	Famotidine	97	35
Montelukast Sodium	Montelukast Sodium	97	31
Metformin Hcl Er	Metformin Hcl	89	32
Hydroxyzine Hcl	Hydroxyzine Hcl	84	37
Glimepiride	Glimepiride	83	25
Duloxetine Hcl	Duloxetine Hcl	80	27
Fluticasone Propionate	Fluticasone Propionate	78	31
Potassium Chloride	Potassium Chloride	77	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	22
Meloxicam	Meloxicam	68	29
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	67	59
Escitalopram Oxalate	Escitalopram Oxalate	66	21
Tramadol Hcl	Tramadol Hcl	65	16
Buspirone Hcl	Buspirone Hcl	63	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	20
Baclofen	Baclofen	61	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	25
Pravastatin Sodium	Pravastatin Sodium	61	23
Venlafaxine Hcl Er	Venlafaxine Hcl	61	16
Warfarin Sodium	Warfarin Sodium	61	22
Clopidogrel	Clopidogrel Bisulfate	59	19
Fluoxetine Hcl	Fluoxetine Hcl	57	15
Ozempic	Semaglutide	57	13
Jardiance	Empagliflozin	55	19
Cephalexin	Cephalexin	54	50
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	17
Terazosin Hcl	Terazosin Hcl	53	17
Atenolol	Atenolol	52	19
Prednisone	Prednisone	47	37
Doxycycline Hyclate	Doxycycline Hyclate	44	40
Nystatin	Nystatin	42	21
Synthroid	Levothyroxine Sodium	42	12
Bupropion Xl	Bupropion Hcl	40	13
Diclofenac Sodium	Diclofenac Sodium	40	19
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	11
Tizanidine Hcl	Tizanidine Hcl	37	19
Lorazepam	Lorazepam	36	20
Alendronate Sodium	Alendronate Sodium	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	11
Celecoxib	Celecoxib	35	13
Spironolactone	Spironolactone	35	13
Valacyclovir	Valacyclovir Hcl	35	17
Methocarbamol	Methocarbamol	32	16
Carvedilol	Carvedilol	30	13
Ezetimibe	Ezetimibe	30	suppressed
Mirtazapine	Mirtazapine	30	13
Alprazolam	Alprazolam	29	15
Pregabalin	Pregabalin	29	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Ketoconazole	Ketoconazole	27	14
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Finasteride	Finasteride	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	14
Propranolol Hcl	Propranolol Hcl	23	11
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Ciclopirox	Ciclopirox	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Topiramate	Topiramate	16	suppressed
Valsartan	Valsartan	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Fluconazole	Fluconazole	15	14
Glipizide	Glipizide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Cefdinir	Cefdinir	13	13
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Torsemide	Torsemide	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error